MEVIS MEDSOL N
MEVIS MEDSOL N operates in Diversified Metals & Mining.
MEVIS MEDSOL N (M3V) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2019: 0.069x
Based on the latest financial reports, MEVIS MEDSOL N (M3V) has a cash flow conversion efficiency ratio of 0.069x as of June 2019.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.60 Million) by net assets (€37.83 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
MEVIS MEDSOL N - Cash Flow Conversion Efficiency Trend (2017–2023)
This chart illustrates how MEVIS MEDSOL N's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
MEVIS MEDSOL N Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MEVIS MEDSOL N ranked by their cash flow conversion efficiency.
Annual Cash Flow Conversion Efficiency for MEVIS MEDSOL N (2017–2023)
The table below shows the annual cash flow conversion efficiency of MEVIS MEDSOL N from 2017 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-09-30 | €17.83 Million | €5.85 Million | 0.328x | +20.52% |
| 2022-09-30 | €17.83 Million | €4.86 Million | 0.272x | -46.80% |
| 2021-09-30 | €17.83 Million | €9.13 Million | 0.512x | +215.97% |
| 2020-09-30 | €17.83 Million | €2.89 Million | 0.162x | -55.84% |
| 2019-09-30 | €17.83 Million | €6.54 Million | 0.367x | +113.19% |
| 2018-09-30 | €32.06 Million | €5.52 Million | 0.172x | -23.55% |
| 2017-09-30 | €32.51 Million | €7.32 Million | 0.225x | -- |